Related Experiment Video
Updated: Mar 8, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified
Yun Lin1, Wei-Ming Chen1, Chen Wang2
1Department of Hematology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
Researchers identified 20 microRNAs (miRNAs) that are significantly altered in peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). These miRNAs may serve as biomarkers for diagnosing PTCL-NOS and understanding its progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous and invasive cancer.
- MicroRNAs (miRNAs) are key gene regulators implicated in various cancers.
Purpose of the Study:
- Identify novel signaling miRNAs to differentiate PTCL-NOS from reactive lymphoid hyperplasia (RLH).
- Explore molecular pathways associated with PTCL-NOS using identified miRNAs.
Main Methods:
- MicroRNA expression profiling in PTCL-NOS and RLH patient samples using panel PCR array.
- Gene Ontology (GO) analysis to assess functions of miRNA targets.
- Pathway enrichment analysis to identify relevant signaling pathways.
Main Results:
- Identified 20 significantly up/down-regulated miRNAs in PTCL-NOS compared to RLH.
- GO and pathway analyses revealed 61 GOs and 34 pathways linked to tumorigenesis, invasion, metastasis, and drug resistance.
Conclusions:
- The 20 identified miRNAs show potential as diagnostic biomarkers for PTCL-NOS.
- These miRNAs may offer insights into the molecular mechanisms driving PTCL-NOS progression.
More Related Videos
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023